Moth Cytochrome C (MCC) 88-103
Need Assistance?
  • US & Canada:
    +
  • UK: +

Moth Cytochrome C (MCC) 88-103

* Please kindly note that our products are not to be used for therapeutic purposes and cannot be sold to patients.

Moth Cytochrome C (MCC) 88-103, derived from the carboxyl terminus of moth cytochrome C, induces positive selection of TCR transgenic thymocytes.

Category
Others
Catalog number
BAT-009285
CAS number
108273-68-3
Molecular Formula
C79H133N23O25
Molecular Weight
1805.04
IUPAC Name
(2S)-6-amino-2-[[(2S,3R)-2-[[(2S)-2-[[(2S)-5-amino-2-[[(2S)-6-amino-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S,3S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-4-amino-2-[[(2S)-2-aminopropanoyl]amino]-4-oxobutanoyl]amino]-4-carboxybutanoyl]amino]-5-carbamimidamidopentanoyl]amino]propanoyl]amino]-3-carboxypropanoyl]amino]-4-methylpentanoyl]amino]-3-methylpentanoyl]amino]propanoyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]amino]-5-oxopentanoyl]amino]propanoyl]amino]-3-hydroxybutanoyl]amino]hexanoic acid
Synonyms
Ala-Asn-Glu-Arg-Ala-Asp-Leu-Ile-Ala-Tyr-Leu-Lys-Gln-Ala-Thr-Lys; L-alanyl-L-asparagyl-L-alpha-glutamyl-L-arginyl-L-alanyl-L-alpha-aspartyl-L-leucyl-L-isoleucyl-L-alanyl-L-tyrosyl-L-leucyl-L-lysyl-L-glutaminyl-L-alanyl-L-threonyl-L-lysine
Purity
≥95%
Density
1.45±0.1 g/cm3 (Predicted)
Sequence
ANERADLIAYLKQATK
Storage
Store at -20°C
Solubility
Soluble in Water (0.60 mg/mL)
InChI
InChI=1S/C79H133N23O25/c1-12-39(6)61(101-75(123)53(33-38(4)5)100-74(122)56(36-60(109)110)98-64(112)41(8)88-67(115)48(20-17-31-87-79(85)86)91-70(118)50(26-28-59(107)108)94-73(121)55(35-58(84)106)96-63(111)40(7)82)76(124)90-42(9)65(113)97-54(34-45-21-23-46(104)24-22-45)72(120)99-52(32-37(2)3)71(119)92-47(18-13-15-29-80)69(117)93-49(25-27-57(83)105)68(116)89-43(10)66(114)102-62(44(11)103)77(125)95-51(78(126)127)19-14-16-30-81/h21-24,37-44,47-56,61-62,103-104H,12-20,25-36,80-82H2,1-11H3,(H2,83,105)(H2,84,106)(H,88,115)(H,89,116)(H,90,124)(H,91,118)(H,92,119)(H,93,117)(H,94,121)(H,95,125)(H,96,111)(H,97,113)(H,98,112)(H,99,120)(H,100,122)(H,101,123)(H,102,114)(H,107,108)(H,109,110)(H,126,127)(H4,85,86,87)/t39-,40-,41-,42-,43-,44+,47-,48-,49-,50-,51-,52-,53-,54-,55-,56-,61-,62-/m0/s1
InChI Key
PETWKYOXTHYCHR-COAXQGQQSA-N
Canonical SMILES
CCC(C)C(C(=O)NC(C)C(=O)NC(CC1=CC=C(C=C1)O)C(=O)NC(CC(C)C)C(=O)NC(CCCCN)C(=O)NC(CCC(=O)N)C(=O)NC(C)C(=O)NC(C(C)O)C(=O)NC(CCCCN)C(=O)O)NC(=O)C(CC(C)C)NC(=O)C(CC(=O)O)NC(=O)C(C)NC(=O)C(CCCNC(=N)N)NC(=O)C(CCC(=O)O)NC(=O)C(CC(=O)N)NC(=O)C(C)N
1. The stimulation of low-affinity, nontolerized clones by heteroclitic antigen analogues causes the breaking of tolerance established to an immunodominant T cell epitope
R Wang, Y Wang-Zhu, C R Gabaglia, K Kimachi, H M Grey J Exp Med. 1999 Oct 4;190(7):983-94. doi: 10.1084/jem.190.7.983.
H-2K mice injected, intravenously in saline or intraperitoneally in incomplete Freund's adjuvant, with large quantities of the immunodominant I-E(k)-restricted epitope from moth cytochrome c (MCC) 88-103 fail to respond to subsequent immunization with this epitope when administered in complete Freund's adjuvant. This state of tolerance can be broken by immunization with certain MCC 88-103 analogues that are heteroclitic antigens as assessed on representative MCC 88-103 specific T cell clones. In this paper, the mechanism of breaking tolerance by heteroclitic antigens was investigated. The following observations were made: (a) T cell hybridomas derived from tolerance-broken animals required higher concentrations of MCC 88-103 to be stimulated than hybridomas derived from normal immune animals, suggesting that they have T cell receptors (TCRs) of lower affinity; (b) in contrast to normal immune animals whose MCC-specific TCRs are typically Vbeta3(+)/Valpha11(+), none of the hybridomas derived from tolerance-broken animals expressed Vbeta3, although they were all Valpha11(+). Also, the Vbeta complementarity determining region 3 (CDR3) regions from the tolerance-broken animals did not contain the canonical structure and length characteristics of the normal MCC 88-103 immune repertoire; and (c) adoptive transfer and tolerization of MCC-specific Vbeta3(+)/Valpha11(+) transgenic T cells followed by immunization with heteroclitic antigen failed to terminate the state of tolerance. Collectively, these data strongly suggest that the mechanism involved in breaking tolerance in this system is the stimulation of nontolerized, low-affinity clones, rather than reversal of anergy. Further support for this mechanism was the finding that after activation, T cells apparently have a lowered threshold with respect to the affinity of interaction with antigen required for stimulation.
2. Cutting edge: MHC class II-restricted peptides containing the inflammation-associated marker 3-nitrotyrosine evade central tolerance and elicit a robust cell-mediated immune response
H Chaim Birnboim, Anne-Marie Lemay, Debbie Ka Yee Lam, Rose Goldstein, John R Webb J Immunol. 2003 Jul 15;171(2):528-32. doi: 10.4049/jimmunol.171.2.528.
Nitrotyrosine is widely recognized as a surrogate marker of up-regulated inducible NO synthase expression at sites of inflammation. However, the potential immunogenicity of autologous proteins containing nitrotyrosine has not previously been investigated. Herein, we used the I-E(K)-restricted T cell epitope of pigeon/moth cytochrome c (PCC/MCC(88-103)) to assess the ability of T cells to recognize ligands containing nitrotyrosine. Substitution of the single tyrosine (Y97) in PCC/MCC(88-103) with nitrotyrosine abrogates recognition by the MCC(88-103)-specific T cell hybridoma 2B4. CBA (H2(K)) mice immunized with MCC(88-103) or nitrated MCC(88-103) peptides produce T cell responses that are mutually exclusive. Transgenic mice that constitutively express PCC under the control of an MHC class I promoter are tolerant toward immunization with MCC(88-103), but exhibited a robust immune response against nitrated MCC(88-103). Analysis of T cell hybridomas specific for nitrated-MCC(88-103) indicated that subtle differences in TCR VDJ gene usage are sufficient to allow nitrotyrosine-specific T cells to escape the processes of central tolerance.
3. Termination of peripheral tolerance to a T cell epitope by heteroclitic antigen analogues
U Zügel, R Wang, G Shih, A Sette, J Alexander, H M Grey J Immunol. 1998 Aug 15;161(4):1705-9.
Treating mice with an immunodominant T cell epitope from moth cytochrome c (MCC(88-103)) can induce T cell unresponsiveness under certain conditions of administration. In this report, we determined whether T cell tolerance to MCC(88-103) in adult animals can be overcome by immunization with cross-reactive analogues of the tolerizing Ag. A panel of analogues of the tolerogen were tested for their capacity to terminate the tolerant state following in vivo immunization. As analyzed by their stimulatory capacity for a representative MCC(88-103)-specific T cell clone, this panel covered a wide range of cross-reactivity, including nonantigenic, antagonistic, weakly, and strongly antigenic peptides. Interestingly, only heteroclitic analogues, as measured in vitro by their enhanced antigenicity for the T cell clone that was specific for MCC(88-103), were capable of breaking tolerance. Thus, an immune response to the cross-reactive, heteroclitic analogues of tolerized self Ags may represent a mechanism by which Ag molecular mimicry operates.
Online Inquiry
Verification code
Inquiry Basket